Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 1

Status

Completed 3Recruiting 1

Sponsor Class

OTHER 3OTHER_GOV 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 4Classical hematology 1

Conditions

Hematologic Neoplasms 4Thrombocytopenia 2Hemorrhage 2Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Leukemia, Myeloid, Acute 1

Interventions

Cyclophosphamide 87fludarabine 77fludarabine phosphate 45Tacrolimus 45Whole-Body Irradiation 42Mycophenolic Acid 42Busulfan 35Melphalan 32Antilymphocyte Serum 24Methotrexate 23thymoglobulin 22Standard of Care 22Rituximab 22venetoclax 20Thiotepa 20Sirolimus 20Azacitidine 20Stem Cell Transplantation 18Granulocyte Colony-Stimulating Factor 18Practice Guidelines as Topic 17Cytarabine 16Bortezomib 16Nivolumab 15Filgrastim 15Specimen Handling 14Dexamethasone 14Blood Specimen Collection 14Cyclosporine 13Surveys and Questionnaires 12Mesna 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Hematologic Neoplasms × Tranexamic Acid × Other hematologic neoplasm × Clear all
NCT04448184 2026-01-08

PATH

Ottawa Hospital Research Institute

Phase 3 Recruiting
662 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT03136445 2025-10-28

TREATT

NHS Blood and Transplant

Phase 3 Completed
616 enrolled 34 charts
Other hematologic neoplasm

Hemorrhage, Hematologic Neoplasms

NCT03801122 2023-05-06

TTRAP-Bleeding

Centre Hospitalier Universitaire de Saint Etienne

Phase 2 Completed
18 enrolled
Classical hematologyOther hematologic neoplasm

Hemorrhage, Thrombocytopenia, Hematologic Neoplasms

NCT02650791 2020-05-18

PATH

Ottawa Hospital Research Institute

Phase 3 Completed
100 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡